NK cell activation in cancer patients following BioBran intake

87th Annual Meeting of the American Association for Cancer Research, 1996
M. Ghoneum and G. Namatalla

NK cell activity was compared before and after 6 months of BioBran intake in 25 advanced cancer patients, who received chemotherapy, surgery, and/or hormone therapy. Although there were large individual differences in NK cell activity at the baseline, all patients demonstrated an increase in NK cell activity after BioBran intake.

This page contains data that has been partially modified from the original graphs in the article for optimal display on the website.